<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Durgin BG</submitter><funding>NIDDK NIH HHS</funding><funding>University of Pittsburgh</funding><funding>NHLBI NIH HHS</funding><funding>American Heart Association Inc</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>72-80</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8766905</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>162</volume><pubmed_abstract>Chronic hypoxia is a major driver of cardiovascular complications, including heart failure. The nitric oxide (NO) - soluble guanylyl cyclase (sGC) - cyclic guanosine monophosphate (cGMP) pathway is integral to vascular tone maintenance. Specifically, NO binds its receptor sGC within vascular smooth muscle cells (SMC) in its reduced heme (Fe&lt;sup>2+&lt;/sup>) form to increase intracellular cGMP production, activate protein kinase G (PKG) signaling, and induce vessel relaxation. Under chronic hypoxia, oxidative stress drives oxidation of sGC heme (Fe&lt;sup>2+&lt;/sup>→Fe&lt;sup>3+&lt;/sup>), rendering it NO-insensitive. We previously showed that cytochrome b5 reductase 3 (CYB5R3) in SMC is a sGC reductase important for maintaining NO-dependent vasodilation and conferring resilience to systemic hypertension</pubmed_abstract><journal>Journal of molecular and cellular cardiology</journal><pubmed_title>Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.</pubmed_title><pmcid>PMC8766905</pmcid><funding_grant_id>1S10OD023684-01A1</funding_grant_id><funding_grant_id>R01 HL133864</funding_grant_id><funding_grant_id>F32 HL152498</funding_grant_id><funding_grant_id>T32 DK007052</funding_grant_id><funding_grant_id>S10 OD023684</funding_grant_id><funding_grant_id>F32 HL 152498-01</funding_grant_id><funding_grant_id>16GRNT27250146</funding_grant_id><funding_grant_id>R01 HL128304</funding_grant_id><funding_grant_id>R01 HL 133864</funding_grant_id><funding_grant_id>DK 007052</funding_grant_id><funding_grant_id>R01 HL 128304</funding_grant_id><pubmed_authors>Durgin BG</pubmed_authors><pubmed_authors>McMahon B</pubmed_authors><pubmed_authors>Baust JJ</pubmed_authors><pubmed_authors>Straub AC</pubmed_authors><pubmed_authors>Wood KC</pubmed_authors><pubmed_authors>Hahn SA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.</name><description>Chronic hypoxia is a major driver of cardiovascular complications, including heart failure. The nitric oxide (NO) - soluble guanylyl cyclase (sGC) - cyclic guanosine monophosphate (cGMP) pathway is integral to vascular tone maintenance. Specifically, NO binds its receptor sGC within vascular smooth muscle cells (SMC) in its reduced heme (Fe&lt;sup>2+&lt;/sup>) form to increase intracellular cGMP production, activate protein kinase G (PKG) signaling, and induce vessel relaxation. Under chronic hypoxia, oxidative stress drives oxidation of sGC heme (Fe&lt;sup>2+&lt;/sup>→Fe&lt;sup>3+&lt;/sup>), rendering it NO-insensitive. We previously showed that cytochrome b5 reductase 3 (CYB5R3) in SMC is a sGC reductase important for maintaining NO-dependent vasodilation and conferring resilience to systemic hypertension</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-21T15:23:08.987Z</modification><creation>2025-04-21T15:23:08.987Z</creation></dates><accession>S-EPMC8766905</accession><cross_references><pubmed>34536439</pubmed><doi>10.1016/j.yjmcc.2021.09.005</doi></cross_references></HashMap>